2018年3期
刊物介紹
本刊主要是及時報道我國在腫瘤防治研究領域包括癌癥基礎理論研究和癌癥預防、臨床治療研究方面的新進展、新成果，內容涉及腫瘤病因學與滸病學，實驗腫瘤學、腫瘤細胞分子生物學，腫瘤病理學以及腫瘤影像診斷、腫瘤外科治療、化學治療、放射治療、介入治療、生物治療和中西醫(yī)結合治療腫瘤等各分支學科，旨在促進國內外學術交流，提高我國癌癥研究與癌癥治療水平。
Chinese Journal of Cancer Research
- Incidence and mortality of stomach cancer in China, 2014
- Incidence and mortality of laryngeal cancer in China, 2008–2012
- Effectiveness and safety of different amifostine regimens:Preliminary results of a phase II multicenter randomized controlled trial
- Combined peripheral natural killer cell and circulating tumor cell enumeration enhance prognostic efficiency in patients with metastatic triple-negative breast cancer
- Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studies
- Presence of circulating tumor cells is associated with metabolicrelated variables in postoperative patients with early-stage breast cancer
- MAT1 correlates with molecular subtypes and predicts poor survival in breast cancer
- Clinicopathological features and surgical outcomes of four rare subtypes of primary liver carcinoma
- Down-staging depth score to predict outcomes in locally advanced rectal cancer achieving ypI stage after neoadjuvant chemo-radiotherapy versus de novo stage pI cohort: A propensity score-matched analysis
- Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma